Permeability and Metabolic Stability of ALK2 Inhibitors
Rima Al‐awar, Ahmed Aman, Mike Briggs, Alex N. Bullock et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
Ahmed Aman
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
167Publications signalées
3913Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
CAR-T cell therapy researchGlioma Diagnosis and TreatmentProtein Degradation and InhibitorsUbiquitin and proteasome pathwaysMonoclonal and Polyclonal Antibodies Research
Publications récentes
Permeability and Metabolic Stability of ALK2 Inhibitors
Rima Al‐awar, Ahmed Aman, Mike Briggs, Alex N. Bullock et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
Cardiac Profiling, Ames Mutagenicity, and CYP Inhibition Profiles of ALK2 Inhibitors
Rima Al‐awar, Ahmed Aman, Mike Briggs, Alex N. Bullock et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
Cardiac Profiling, Ames Mutagenicity, and CYP Inhibition Profiles of ALK2 Inhibitors
Rima Al‐awar, Ahmed Aman, Mike Briggs, Alex N. Bullock et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
Pharmacokinetics of brain-penetrant, orally bioavailable ALK2 inhibitor
Rima Al‐awar, Ahmed Aman, Mike Briggs, David H. Drewry et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
Pharmacokinetics of brain-penetrant, orally bioavailable ALK2 inhibitor
Rima Al‐awar, Ahmed Aman, Mike Briggs, David H. Drewry et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
Pharmacokinetics of brain-penetrant, orally bioavailable ALK2 inhibitor
Rima Al‐awar, Ahmed Aman, Mike Briggs, David H. Drewry et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
Biochemical, Cellular Target Engagement, and Functional Assay Data for ALK2 Inhibitors
Rima Al‐awar, Ahmed Aman, Alex N. Bullock, Sue Cramp et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
Biochemical, Cellular Target Engagement, and Functional Assay Data for ALK2 Inhibitors
Rima Al‐awar, Ahmed Aman, Alex N. Bullock, Sue Cramp et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
Extended Kinase Selectivity and SafetyScreen44 Profiling Data for ALK2 Inhibitors
Rima Al‐awar, Ahmed Aman, Alex N. Bullock, David H. Drewry et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
Extended Kinase Selectivity and SafetyScreen44 Profiling Data for ALK2 Inhibitors
Rima Al‐awar, Ahmed Aman, Alex N. Bullock, David H. Drewry et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
Pharmacokinetics of brain-penetrant, orally bioavailable ALK2 inhibitor
Rima Al‐awar, Ahmed Aman, Mike Briggs, David H. Drewry et autres
0 citationsZenodo (CERN European Organization for Nuclear Research)
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.